The genetic basis of Fanconi anemia (FA) is mysterious and complex, as none of the five genes previously associated with the disorder have homology to genes encoding proteins of known function.

The Redditor, who is battling liver cancer, mouth cancer, and a rare genetic condition, Fanconi Anemia, posted a heartfelt ...

Ethan Fisher, the son of Texas A&M head football coach Jimbo Fisher, spoke with GigEm247 about his journey with Fanconi anemia, how he got into kicking and his verbal commitment to Samford.

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) shared encouraging updates on its Danon Disease Program through a recent investor ...

On Monday, Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) presented long-term safety and efficacy results from the Phase 1 study ...

Analyst Eric Joseph of J.P. Morgan maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), retaining the price target of ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today ...

Rocket Pharma ( (RCKT) ) has released its Q3 earnings. Here is a breakdown of the information Rocket Pharma presented to its investors.Don't ...

Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer.